FDA Approved: TOVIAZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental labeling application for TOVIAZ (fesoterodine fumarate) from Pfizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Toviaz (fesoterodine fumarate)

Snippet

SUPPL AP for TOVIAZ (FESOTERODINE FUMARATE)